Health status of newborns from mothers with HCV infection




HCV infection, health status, newborns, physical parameters, Apgar score


Purpose - to study the health status of newborns from mothers with viral hepatitis С (HCV infection).

Materials and methods. A prospective clinical and statistical analysis of the health status of 40 newborns born to mothers with HCV infection (the main group - MG) and 50 newborns born to healthy women (the control group - CG) was performed. The statistical processing of the study results was carried out using standard software Microsoft Excel 5.0 and Statistica 8.0.

Results. In children of MG compared to children of CG had a lower Apgar score at birth (p<0.001). An Apgar score ˂7 points in 15.0% (6/40) of newborns of MG (F=4.61; p=0.032) was diagnosed, which was significantly higher than in newborns of CG - 4.0% (2/50), (р<0.001). The frequency of conjugated jaundice in newborns of CG was 4.0% (2/50), while in children of MG it was 17.5% (7/40) (χ2=7.97; p=0.005). Correlation analysis revealed that the Apgar score has medium strength positive correlations with body length (τ=0.266; p<0.001), and the development of conjugated jaundice in newborns has medium negative correlations with these physical parameters at birth as body weight (τ=-0.302; p<0.001) and body length (τ=-0.306; p<0.001), as well as with Apgar score (τ=-0.302; p<0.001) and gestational age at birth (τ=-0.249; p<0.001).

Conclusions. The condition of newborns from women with HCV infection is characterized by lower parameters of physical development and a decrease in Apgar score, increased frequency of development of conjugation jaundice. Physical and clinical parameters of newborns from mothers with HCV infection were related to pathological conditions during pregnancy and delivery.

The research was carried out in accordance with the principles of the Helsinki Declaration. The study protocol was approved by the Local Ethics Committee of the participating institution. The informed consent of the patient was obtained for conducting the studies.

No conflict of interests was declared by the author.


Barritt AS, Jhaveri R. (2018). Treatment of Hepatitis C during Pregnancy-Weighing the Risks and Benefits in Contrast to HIV. Current HIV/AIDS reports. 15 (2): 155-161.; PMid:29470782

Chilaka VN, Konje JC. (2021). Viral Hepatitis in pregnancy. European journal of obstetrics, gynecology, and reproductive biology. 256: 287-296.; PMid:33259998

Compagnone A, Catenazzi P, Riccardi R, Zuppa AA. (2019). Mother-to-child transmission of hepatitis C virus. Minerva pediatrica. 71 (2): 174-180.; PMid:29968442

Dibba P, Cholankeril R, Li AA, Patel M, Fayek M, Dibble C et al. (2018). Hepatitis C in Pregnancy. Diseases (Basel, Switzerland). 6 (2): 31.; PMid:29702563 PMCid:PMC6023348

Hofstraat S, Falla AM, Duffell EF, Hahné S, Amato-Gauci AJ, Veldhuijzen IK, Tavoschi L. (2017). Current prevalence of chronic hepatitis B and C virus infection in the general population, blood donors and pregnant women in the EU/EEA: a systematic review. Epidemiology and infection. 145 (14): 2873-2885.; PMid:28891457 PMCid:PMC5647665

Huang QT, Hang LL, Zhong M, Gao YF, Luo ML, Yu YH. (2016). Maternal HCV infection is associated with intrauterine fetal growth disturbance: A meta-analysis of observational studies. Medicine. 95 (35): e4777.; PMid:27583932 PMCid:PMC5008616

Kushner T, Djerboua M, Biondi MJ, Feld JJ, Terrault N, Flemming JA. (2022). Influence of hepatitis C viral parameters on pregnancy complications and risk of mother-to-child transmission. Journal of hepatology. 77 (5): 1256-1264.; PMid:35643203

Mateyko HB, Matvisiv MV. (2017). Risk of the fetus and newborn infection in pregnant women with HBV- and HCV-infection. Infectious diseases. 2: 9-14.

Mavilia MG, Wu GY. (2017). Mechanisms and Prevention of Vertical Transmission in Chronic Viral Hepatitis. Journal of clinical and translational hepatology. 5 (2): 119-129.; PMid:28660149 PMCid:PMC5472932

Mintser AP. (2018). Statisticheskie metodyi issledovaniya v klinicheskoy meditsine. Prakticheskaya meditsina. 3: 41-45.

Pfaender S, Heyden J, Friesland M, Ciesek S, Ejaz A, Steinmann J et al. (2013). Inactivation of hepatitis C virus infectivity by human breast milk. The Journal of infectious diseases. 208 (12): 1943-1952.; PMid:24068703

Public Health Center. (2018). Hepatitis C in Ukraine: epidemiological characteristics and severity assessment. URL:

Ragusa R, Corsaro LS, Frazzetto E, Bertino E, Bellia MA, Bertino G. (2020). Hepatitis C Virus Infection in Children and Pregnant Women: An Updated Review of the Literature on Screening and Treatments. AJP reports. 10 (1): e121-e127.; PMid:32257593 PMCid:PMC7108952

Reid S, Day CA, Bowen DG, Minnis J, Ludlow J, Jacobs S et al. (2018). Vertical transmission of hepatitis C: Testing and health-care engagement. Journal of paediatrics and child health. 54 (6): 647-652.; PMid:29292561

Roudot-Thoraval F. (2021). Epidemiology of hepatitis C virus infection. Clinics and research in hepatology and gastroenterology. 45 (3): 101596.; PMid:33610022

Tosone G, Maraolo AE, Mascolo S, Palmiero G, Tambaro O, Orlando R. (2014). Vertical hepatitis C virus transmission: Main questions and answers. World journal of hepatology. 6 (8): 538-548.; PMid:25232447 PMCid:PMC4163737

Towers CV, Fortner KB. (2019). Infant follow-up postdelivery from a hepatitis C viral load positive mother. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians. 32 (19): 3303-3305.; PMid:29587561

Znovets TV, Baranovskaya EI, Zhavoponok CB, Znovets IA. (2018). Perinatal outcomes of HCV infection. Medical Journal. 4: 57-61.